Van Nyen, Tom https://orcid.org/0000-0002-6160-468X
Planque, Mélanie
van Wagensveld, Lilian https://orcid.org/0000-0003-4036-3554
Duarte, Joao A. G.
Zaal, Esther A. https://orcid.org/0000-0001-9890-7345
Talebi, Ali
Rossi, Matteo
Körner, Pierre-René
Rizzotto, Lara
Moens, Stijn
De Wispelaere, Wout
Baiden-Amissah, Regina E. M. https://orcid.org/0000-0003-3071-7726
Sonke, Gabe S.
Horlings, Hugo M. https://orcid.org/0000-0003-4782-8828
Eelen, Guy https://orcid.org/0000-0003-3354-5819
Berardi, Emanuele https://orcid.org/0000-0002-0775-9605
Swinnen, Johannes V. https://orcid.org/0000-0002-7720-5077
Berkers, Celia R. https://orcid.org/0000-0003-0746-8565
Carmeliet, Peter https://orcid.org/0000-0001-7961-1821
Lambrechts, Diether https://orcid.org/0000-0002-3429-302X
Davidson, Ben
Agami, Reuven https://orcid.org/0000-0002-2848-2473
Fendt, Sarah-Maria https://orcid.org/0000-0001-6018-9296
Annibali, Daniela https://orcid.org/0000-0001-8413-7669
Amant, Frédéric https://orcid.org/0000-0002-5452-4905
Article History
Received: 29 March 2022
Accepted: 19 July 2022
First Online: 5 August 2022
Competing interests
: S.M.F. has received funding from Bayer, Merck and BlackBelt Therapeutics and has consulted for Fund+. G.S.S. reports institutional research support from AstraZeneca, Merck, Novartis, and Roche, unrelated to this work. All the other authors declare no competing interests.